Study: Pembrolizumab + chemo, trastuzumab beneficial in gastroesophageal cancer
For patients with HER2-positive gastroesophageal junction (GEJ) adenocarcinoma, pembrolizumab improves progression-free survival when combined with chemotherapy and trastuzumab, according to a study published online Oct. ...
Oct 25, 2023
0
1